Form 10-K ARTELO BIOSCIENCES, INC For: Aug 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides .
Artelo BiosciencesJanuary 14, 2021 GMT
Received Clinical Trial Authorization to Commence Cancer Appetite Recovery Phase I/II Clinical Study of ART27.13 in UK
Awarded Mitacs Accelerate Grant
LA JOLLA, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today reported financial and operating results for the first quarter of its fiscal year ended November 30, 2020 and provided a business update.